🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join us tonight as we assess 40 years of HIV response for Uganda, the challenges we have encountered and how we can do better. See you at 8 x.com/i/spaces/1OdKr…

Just released! 💥 #LEN, the twice-yearly injectable #PrEP has the potential to transform the #HIV response, but only if it is rolled out with speed, scale and equity. Read the latest op-ed from AVAC’s ED Mitchell Warren and Dr. Jirair Ratevosian in Devex. devex.com/news/opinion-t…

.Gilead Sciences Submits New Drug Application to U.S. Food and Drug Administration for Twice-Yearly Lenacapavir for HIV Prevention gilead.com/company/compan… via @Gilead

Positive steps toward rolling #LEN for #PrEP out with speed, scale & equity, but more more needs to happen. ICYMI, Gilead Sciences filed to US FDA and PEPFAR & The Global Fund announced a coordinated effort to reach 2M people with access to LEN. Read more: avac.org/blog/accelerat…

An op-ed on the potential of #LEN penned by AVAC's executive director Mitchell Warren and Dr. Jirair Ratevosian in Devex, Gilead plans to halt free access to #HIV drug, worrying advocates, and more in the final #NewsDigest of 2024. 📰 Read on and subscribe! avac.org/weekly-newsdig…

#DonaldTrump’s rule will almost certainly mean less money for the US government’s #Aids fund #Pepfar. SA has received R145-billion from the fund since 2003. What now? Mia Malan spoke to AVAC’s Mitchell Warren. bhekisisa.org/multimedia/pod…

Throughout 2024, we have seen rising rates of #syphilis globally. 🌐 Explore #STIWatch to learn the latest about #STI vaccine and diagnostic R&D for syphilis and other STIs. stiwatch.org

Advocating for #PrEP with speed, scale and equity will be an essential part of our work in 2025. Kick-off the year by bookmarking #PrEPWatch for the latest in research & development (R&D), implementation and #PrEP initiations worldwide. 🌐 Explore more at prepwatch.org

2024 has been full of rich and invigorating conversations on our podcast #PxPulse, ranging on topics such as LGBTQ+ rights in Uganda, choice and #HIV prevention, how the US election impacts public health and more. Join us for a season of listening at avac.org/px-pulse 🎧

Among his many contributions, #JimmyCarter was a pioneer in global health. A great summary from Stephanie Nolen: nytimes.com/2024/12/30/hea… — with this essential lesson for Melinda French Gates

From the implementation of #DoxyPEP, to the trial results of #LEN for #PrEP, there have been major strides in #HIV and #STI prevention in 2024. AVAC’s resources track it all to inform your advocacy. See our top 🔟 most downloaded resources of 2024 at avac.org/2024MostDownlo…

One of the biggest news items of 2024 was the incredible effectiveness of injectable lenacapavir for #HIV prevention. But can the world translate this science into public health impact? Our Mitchell Warren and Dr. Jirair Ratevosian think so — and explain how in this Devex commentary 👇

#DonaldTrump’s rule will almost certainly mean less money for the US government’s #Aids fund #Pepfar. SA has received R145-billion from the fund since 2003. What now? Mia Malan spoke to AVAC’s Mitchell Warren. bhekisisa.org/multimedia/pod…

Prevention is needed to #ENDAIDS Freeze on global HIV prevention efforts sparks disbelief, anger | Science | AAAS science.org/content/articl… Gabby Stern World Health Organization (WHO)